INSMED INC Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period
INSMED INC (INSM) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period of 160.05 thousand shares for the 12-month period ending 2012-12-31, per its 10-K filed 2013-03-18.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod · last filed 2013-03-18
- INSMED INC share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2012-12-31 was 104.80K shares.
- INSMED INC share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2012-09-30 was 97.00K shares.
- INSMED INC share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2012 was 160.05K shares, a 92.08% increase from fiscal 2011.
- INSMED INC share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2011 was 83.32K shares, a 85.16% increase from fiscal 2010.
- INSMED INC share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2010 was 45.00K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 12 month |
|---|---|---|---|---|
| 2012-12-31 | 104.80K shares derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | 201.80K shares derived: sum of 2 quarters · filed 2013-03-18 | 160.05K shares 10-K · filed 2013-03-18 | |
| 2012-09-30 | 97.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-07 | 55.25K shares 10-Q · filed 2012-11-07 | ||
| 2012-06-30 | -41.75K shares 10-Q · filed 2012-08-07 | |||
| 2011-12-31 | 83.32K shares 10-K · filed 2013-03-18 | |||
| 2010-12-31 | 45.00K shares 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |